Shai_Halud / Shutterstock.com
Drugs company Horizon Pharma has agreed to settle a patent dispute centring on a proposed generic version of its anti-inflammatory drug Pennsaid (diclofenac sodium topical solution).
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Horizon Pharma, patent, licensing, Taro Pharmaceutical Industries, Pennsaid, patent licensing